Co-Diagnostics, Inc. Honored at Utah Business 2025 Innovation Awards Summit

Core Insights - Co-Diagnostics, Inc. has been recognized at the Utah Business 2025 Innovation Awards Summit for its Co-Dx PCR platform in the Healthcare and Life Sciences category [1][2] - The award was accepted by CEO Dwight Egan, highlighting the company's innovative approach to molecular diagnostics [2][3] - The Co-Dx PCR platform aims to improve access to high-quality PCR diagnostics globally, with commercialization expected next year [3] Company Overview - Co-Diagnostics, Inc. is a molecular diagnostics company based in Utah, specializing in the development, manufacturing, and marketing of advanced diagnostic technologies [4] - The company's proprietary technology is utilized for tests designed to detect and analyze nucleic acid molecules (DNA or RNA) [4] - Co-Diagnostics also focuses on creating specific tests for its Co-Dx PCR at-home and point-of-care platform, as well as identifying genetic markers for various applications beyond infectious diseases [4]